Responsibility

oncology
pain
dependence
respiratory-tract

Mundipharma assumes responsibility

Mundipharma values ethical behaviour as well as assuming social, economic, and environmental responsibility.

Responsibility for employees

We aim to provide all employees with a healthy work-life balance. Occupational health care and a comprehensive health management serve as a basis to promote health awareness among employees. Group fitness activities and seminars on healthy nutrition are also organised.

Flexible working models provide freedom for employees, thus promoting creativity and individuality in their daily work. Social benefits such as accident and pension plans also promote employee satisfaction.

Environmental responsibility

Our research and actions serve one goal: to maintain personal health. A healthy environment is no less important, which is why environmental protection is part of our corporate philosophy. Because the environment is so important, we reimburse travel expenses for all employees who use public transportation to travel to and from work.

We also work with modern electronic archiving systems in order to minimise the use of paper. The packaging for our meals is also plastic-free.

Only a healthy environment can sustain our health and quality of life.

Our responsibility in opioid management

At Mundipharma Austria we are committed to developing a diverse portfolio of medicines and devices that meet societal needs. We aim to conduct our business in an ethical, transparent and responsible way, doing what’s right for our employees and partners, while contributing to the communities within which we operate. We look at things from a different perspective and are experts at identifying and developing the potential of medical innovations to help improve patient’s lives in meaningful ways.

We have a proud, 30-year heritage in pain management in Austria and are committed to enabling healthcare professionals to treat their patients in pain safely and responsibly.

As an organisation that distributes opioids, we believe we have a responsibility to take measures to minimise the risk of misuse and abuse of these medicines while not depriving the patients that need them.

We recognise that misuse and abuse of pain medications can lead to addiction, overdose and death, and we are aware of the public health risk these potent medications can create, especially when they are diverted, misused and/or abused. That’s why we are committed to reducing the risk of misuse and abuse through a secure supply chain, appropriate education of healthcare professionals, responsible sales and marketing and close collaboration with government authorities and medical organisations.

We fund educational initiatives in line with industry regulations that clearly communicate the facts about opioid medicines in a balanced and responsible manner, outlining both risks and benefits and helping to ensure that our medicines are prescribed only to the right patient for the right reasons.

We are also committed to finding new approaches to the management of pain, including research into new mechanisms and medicines with the potential to reduce or avoid the need for opioids.

Heroin and opioid addiction is also an emerging problem in our community, and this population is often overlooked. We are encouraged that our medicines also play an important role in addiction rehabilitation treatment programmes to help this under-served community.

The support self-help groups, patient organisations, charities, and NPOs

2016

Facilities

Reasons for Support

Contribution

„Atelier de La Tour“ Art Workshop Support for artists with special needs
EUR 2.000,–
Allianz chronischer Schmerz (EURAG)Website supportEUR 2.000,–
Ludwig Boltzmann Institut, WienFunding of research projects for “LBI für Angewandte Lungenfunktionsforschung”EUR 20.000,–
Österreichische ApothekerkammerSupport for the project of the Austrian Chamber of Pharmacists and the ÖGP for the prevention of bronchial asthma and COPD “10 Minuten für meine Lunge”EUR 5.000,–
Österreichische ApothekerkammerSupport for the aspirant course with visual aidsDonation of medicines
Österreichische SchmerzgesellschaftSupport for the project „Statement: Perioperative Pain Treatment“EUR 4.000,–
Österreichische SchulsporthilfeFunding of new PC sets for the use of learning softwareEUR 168,–
Pro Mente OÖSupport for the project „KICO – Unterstützung für Kinder und Jugendliche in sucht- und psychisch belasteten Familien“EUR 15.000-

 

2015

Facilities

Reasons for Support

Contribution

Medizinische Universität Wien – Universitätsklinik für Innere Medizin ISupport for „Initiative Krebsforschung – Krebsforschungslauf“
EUR 1.380,–
Große SchritteSupport for the initiative “GROSSE SCHRITTE” against cystic fibrosisEUR 1.000,–
Subvenire – Verein zur Unterstützung von Menschen in NotSupport for „Kinder-Palliativ-Netzwerk“EUR 1.000,–
Griechenlandhilfe – Verein für humanitäre Hilfe in GriechenlandDonation of medicines

 

2014

Facilities

Reasons for Support

Contribution

Allianz chronischer Schmerz (EURAG) Support of Website
EUR 2.000,–
Universitätsklinik f. Innere Medizin, Wien pilot project: telemedical Support of cancer patients and caregivers in palliative careEUR 800,–
Ludwig Boltzmann Institut, Wien Funding of Research of the LBI for applied cancer researchEUR 2.000,–
Stiftung Kindertraum Supporting of meet a wish for seriously ill and disabled childrenEUR 1.000,–
Österreichische Schulsporthilfe Supporting of the “Pausenkisten-Aktion” for the primary school in NeubauEUR 1.580,–

 

2013

Facilities

Reasons for Support

Contribution

Lions Club Fürstenfeld EventEUR 1.000,–
Ludwig Boltzmann Institut, Wien Funding of Research of the LBI for applied cancer researchEUR 2.000,–
Debra DonationEUR 1.056,–

 

2012

Facilities

Reasons for Support

Contribution

Allianz chronischer Schmerz (EURAG) Support of Website
EUR 2.000,–
HOSPIZ Österreich Support for the Project “Assessment for hospice and palliative care in austrian care retirement homes”EUR 10.000,–
Help 4 you Company Support of EventEUR 1.500,–